A review of immune checkpoint inhibitor-associated myocarditis: Epidemiology, pathogenesis, and biomarkers

Immune checkpoint inhibitor (ICI) have demonstrated efficacy in treating various cancers by modulating the immune system, but this can lead to immune-related adverse events (irAEs), including myocarditis. ICI-associated myocarditis is a rare but highly lethal irAE with a short mean time to onset, an...

Full description

Saved in:
Bibliographic Details
Main Authors: Le Xu, Yukai Chen, Lin Xiong, Yang Shen, Zhuolin Zhou, Siyu Wang, Ximing Xu
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2025.2512645
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items